Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Protocol for a Randomized Controlled Trial Investigating Effects on Clinical Outcomes, Adherence, and Quality of Life

JMIR Research Protocols
Malin Johansson ÖstbringLina Hellström

Abstract

Preventive treatment goals for blood pressure and cholesterol levels continue to be unmet for many coronary patients. The effect of drug treatment depends on both its appropriateness and the patients' adherence to the treatment regimen. There is a need for adherence interventions that have a measurable effect on clinical outcomes. This study aims to evaluate the effects on treatment goals of an intervention designed to improve patient adherence and treatment quality in secondary prevention of coronary heart disease. A protocol for the prespecified process evaluation of the trial is published separately. The Motivational Interviewing and Medication Review in Coronary heart disease (MIMeRiC) trial is a prospective, randomized, outcomes-blinded trial designed to compare individualized follow-up by a clinical pharmacist using motivational interviewing (MI) and medication review with standard follow-up. Patients were randomized to 2 groups after stratification according to their beliefs about medicines. After standard follow-up at the cardiology clinic, patients in the intervention group are seen individually by a clinical pharmacist 2 to 5 times as required over 7 months, at the clinic. The pharmacist reviews each patient's medicat...Continue Reading

Associated Clinical Trials

References

Apr 22, 2008·The Cochrane Database of Systematic Reviews·R B HaynesX Yao
May 6, 2008·The Journal of Clinical Hypertension·Donald E MoriskyHarry J Ward
Jan 16, 2010·Stroke; a Journal of Cerebral Circulation·Eva-Lotta GladerMichael Lundberg
Dec 15, 2010·Journal of Clinical Epidemiology·Donald E Morisky, M Robin DiMatteo
Feb 15, 2011·European Journal of Clinical Pharmacology·Lina M HellströmTommy Eriksson
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
May 24, 2011·International Journal of Cardiology·Berglind LibunganJohan Herlitz
Apr 11, 2012·British Journal of Clinical Pharmacology·Bernard VrijensUNKNOWN ABC Project Team
Jul 24, 2012·European Journal of Preventive Cardiology·Neil OldridgeUNKNOWN (for the HeartQoL Project Investigators)
Aug 31, 2013·International Journal of Clinical Pharmacy·Janet KrskaPhilip H Rowe
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Apr 12, 2014·Journal of the American Heart Association·Valérie SantschiGilles Paradis
Nov 5, 2014·British Journal of Clinical Pharmacology·Mary A De VeraDiane Lacaille
Nov 21, 2014·The Cochrane Database of Systematic Reviews·Robby NieuwlaatR Brian Haynes
Apr 2, 2015·The New England Journal of Medicine·Gregory A RothChristopher J L Murray
Nov 7, 2015·Journal of the American College of Cardiology·Steven P DunnMary Norine Walsh
Mar 30, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Vicki S ConnPamela S Cooper
May 11, 2016·Journal of General Internal Medicine·Ana PalacioLeonardo Tamariz
Jun 30, 2016·BMJ : British Medical Journal·Anthony MatthewsKrishnan Bhaskaran
Jul 6, 2016·Journal of Advanced Nursing·Ali Hussein Al-GanmiAbdulellah Modhi Alotaibi
Aug 24, 2016·Heart·Prachi BhatnagarNick Townsend
Dec 22, 2016·The Cochrane Database of Systematic Reviews·Mieke L van DrielRichard Deichmann
Mar 21, 2017·Preventive Medicine·Vicki S Conn, Todd M Ruppar

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
coronary artery bypass

Clinical Trials Mentioned

NCT02102503

Software Mentioned

HeartQoL
SEPHIA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.